# Anti-inflammatory Efficacy for Prophylaxis of Cystoid Macular Edema (CME) After Phacoemulsification

> **NCT02084576** · PHASE4 · COMPLETED · sponsor: **Hospital Oftalmologico de Brasilia** · enrollment: 40 (actual)

## Conditions studied

- Cystoid Macular Edema
- Cataract

## Interventions

- **DRUG:** Nepafenac
- **DRUG:** Ketorolac

## Key facts

- **NCT ID:** NCT02084576
- **Lead sponsor:** Hospital Oftalmologico de Brasilia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2013-08
- **Final completion:** 2014-02
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2014-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02084576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02084576, "Anti-inflammatory Efficacy for Prophylaxis of Cystoid Macular Edema (CME) After Phacoemulsification". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02084576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*